chevron_leftBack
As of 24 April 2025, Genus plc has a market cap of $1.41B USD, ranking #6690 globally and #205 in the United Kingdom. It ranks #639 in the Healthcare sector, and #160 in the Biotechnology industry.
Key Stats
Market Cap
$1.41BUSD
1.06B GBP
Enterprise Value
$1.74BUSD
1.31B GBP
Revenue (TTM)
$891.05MUSD
671.6M GBP
EBITDA (TTM)
$99.51MUSD
75.0M GBP
Net Income (TTM)
-$5.31MUSD
-4.0M GBP
EBITDA Margin
11%
Profit Margin
-0.6%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Jorgen Kokke
open_in_new
Employees
3,500
Founded
1994
Website
genusplc.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.5% | -6.1% | -18% | -8.8% | -20% | -6.5% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
GNS
Genus PLC
ISIN: GB0002074580
Shares Out.:
Shares Outstanding:
65.692M1
Shares Float:
64.309M2
|
1.61K GBX | |
|
GENSF
Genus PLC
ISIN: GB0002074580
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
21.00 USD | |
|
GENSY
Genus PLC ADR
ISIN: US37253G1004
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
24.34 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Genus plc
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. Further, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
